Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Russell

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|February 27, 2004
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndromeA Sefcick, D Sowter, E DasGupta, et al.
Journal of Clinical Pathology|March 1, 1995
Functional hyposplenism following allogeneic bone marrow transplantationR J Cuthbert, A Iqbal, A Gates, et al.
Leukemia & Lymphoma|January 1, 1995
Biological features of leukaemic cells associated with autonomous growth and reduced survival in acute myeloblastic leukaemiaN H Russell, A E Hunter, D Bradbury, et al.
British Journal of Haematology|June 1, 1988
Transferrin receptor expression of AML blasts is related to their proliferative potentialR Kozlowski, I A Reilly, D Sowter, et al.
Bone Marrow Transplantation|March 27, 2007
Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreakB E Shaw, T Boswell, J L Byrne, et al.
Bone Marrow Transplantation|September 1, 1995
Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSFA Haynes, A Hunter, G McQuaker, et al.
British Journal of Haematology|July 1, 1997
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamideI G McQuaker, A P Haynes, C Stainer, et al.
Bone Marrow Transplantation|December 16, 1998
Stem cell mobilisation in lymphoproliferative diseasesN H Russell, G McQuaker, C Stainer, et al.
Leukemia|September 25, 2009
Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemiaM Jawad, C Seedhouse, U Mony, et al.
Cancer Genetics and Cytogenetics|March 8, 2000
Pentasomy 8 in acute monoblastic leukemiaJ Gould, A Iqbal, M Heath, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|February 27, 2004
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndromeA Sefcick, D Sowter, E DasGupta, et al.
Journal of Clinical Pathology|March 1, 1995
Functional hyposplenism following allogeneic bone marrow transplantationR J Cuthbert, A Iqbal, A Gates, et al.
Leukemia & Lymphoma|January 1, 1995
Biological features of leukaemic cells associated with autonomous growth and reduced survival in acute myeloblastic leukaemiaN H Russell, A E Hunter, D Bradbury, et al.
British Journal of Haematology|June 1, 1988
Transferrin receptor expression of AML blasts is related to their proliferative potentialR Kozlowski, I A Reilly, D Sowter, et al.
Bone Marrow Transplantation|March 27, 2007
Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreakB E Shaw, T Boswell, J L Byrne, et al.
Bone Marrow Transplantation|September 1, 1995
Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSFA Haynes, A Hunter, G McQuaker, et al.
British Journal of Haematology|July 1, 1997
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamideI G McQuaker, A P Haynes, C Stainer, et al.
Bone Marrow Transplantation|December 16, 1998
Stem cell mobilisation in lymphoproliferative diseasesN H Russell, G McQuaker, C Stainer, et al.
Leukemia|September 25, 2009
Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemiaM Jawad, C Seedhouse, U Mony, et al.
Cancer Genetics and Cytogenetics|March 8, 2000
Pentasomy 8 in acute monoblastic leukemiaJ Gould, A Iqbal, M Heath, et al.
Pageof 16